The use of tumor marker tests has increased progressively in the last decade concomitant with the advent of new monoclonal antibodies and their growing use in clinical oncology for various follow-up programs. External quality assessment (EQA) schemes widely adopted in clinical chemistry, have been extended in the last decade to immunoassays of hormones and tumor markers. EQA results can provide realistic information on the quality of the assays, performed under routine conditions. The goal of this article is to report the main results and discrepancies encountered so far in External Quality Assessment programs on tumor markers.
Möller JensenO., EsteveJ., MollerH., RenardH.Cancer in the European Community and its member states.Eur J Cancer1990; 26: 1167–256.
2.
RittenhouseH.G., ManderinoG.L., HassG.M.Mucintype glycoproteins as tumor markers.Lab Medicine1985; 8: 556–9.
3.
BombardieriE.I marcatori tumorali circolanti in oncologia medica: stato dell'arte, aspetti critici, prospettive.Ligand Quarterly1988; 7: 299–307.
4.
SethJ., SturgeonC.M., Al SadieR., HanningI., EllisA.R.External assessment of immunoassay of peptide hormones and tumor markers: principles and practice.Ann Ist Super Sanità1991; 27: 443–52.
5.
RöhleG., VoigtU., KruseR., OberdörsterW., BreuerH.External quality control of determinations of tumor associated antigens. In: RIA and related procedures in medicine.IAEA1982; 645–52.
6.
PiloA., ZucchelliG.C., MasiniS., TorreG.C., BallestaA.M.Progress report on an external quality assessment program for immunoassay of tumor markers.J Nucl Med Allied Sci1990; 3(Suppl 3): 75–82.
7.
WoodW.G.Immunoassay external quality assessment in the Federal Republic of Germany.Ann Ist Super Sanità1991; 27: 495–8.
8.
AndreottiA., BagniB., BaraghiniG.F., BolelliG.F., BugiardiniG.Le analisi di laboratorio.Edizioni Artestampa-Modena1991.
9.
PiloA., ZucchelliG.C., ChiesaM.R., MasiniS., ClericoA.The CNR external quality assessment program for immunoassay: statistical analysis and reports for participants.Ann Ist Super Sanità1991; 27: 469–78.
10.
External quality assessment of assays for hormones and tumor markers in Italian laboratories.Ann Ist Super Sanità1991; 27: 479–86.
11.
SignoriniC.Le iniziative della Comunità Europea per la standardizzazione degli immunodosaggi.Ligand Quarterly1992; 11: 80–2.
12.
TorreG.C., DominguezM.J., AimoG., PecchioF.Protocols for clinical evaluation of data in tumor biological marker assay.J Nucl Med Allied Sci1990; 34(Suppl 3): 83–8.
13.
GardiniA.Development of quality assurance in Italy.BMJ1992; 304: 703–5.
14.
GionM., MioneR., DittadiR., GattiG., BruscagninG.Marcatori tumorali cirolanti: importanza di un corretto impiego del bilancio costo/beneficio.Argomenti Oncol1989; 10: 423–30.
15.
Van DalenA.Quality control and standardization of Tumour marker tests.Tumor Biol199314: 131–5.
